Literature DB >> 3264518

Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines.

C W Wan1, M K McKnight, D E Brattain, M G Brattain, L C Yeoman.   

Abstract

The growth response to epidermal growth factor (EGF) and the numbers and types of EGF receptors were studied in three human colon tumor cell lines from each of two groups of cell lines that differ markedly in their growth properties and extent of differentiation. Aggressively growing and poorly differentiated colon cells (group I) did not respond to EGF alone, while less aggressively growing and more differentiated cells (group III) responded with increased growth when EGF was added to their chemically defined, serum-free medium. The average number of EGF receptors (EGF-R) measured at the surface of group III cell lines by radioligand binding assays, was eight-fold higher than that measured for group I cell lines. These observations provide evidence for possible autocrine mechanisms that maintain available EGF-R levels in more differentiated group III colon tumor cells and down-regulate EGF-R levels in group I colon tumor cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264518     DOI: 10.1016/0304-3835(88)90226-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Proliferative potential and expression of cell type specific functions in primary mouse colonic epithelial cells.

Authors:  C Branting; U G Allinger; R Toftgard; J Rafter
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

2.  Phenotype alteration in colon carcinoma cells: effect of in vivo passage?

Authors:  M A Maley; A K House; D J Jenkyn; G Sterrett
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation.

Authors:  Guofeng Xie; Zhongsheng Peng; Jean-Pierre Raufman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-23       Impact factor: 4.052

4.  Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor.

Authors:  M D Basson; I M Modlin; J A Madri
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

5.  Regulation of transforming growth factor alpha expression in a growth factor-independent cell line.

Authors:  G M Howell; L E Humphrey; B L Ziober; R Awwad; B Periyasamy; A Koterba; W Li; J K Willson; K Coleman; J Carboni; M Lynch; M G Brattain
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

Review 6.  Targeting the epidermal growth factor receptor in the treatment of colorectal cancer: state of the art.

Authors:  Robert B Diasio; Jeanne Fourie
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.

Authors:  Alexander A Parikh; Fan Fan; Wen Biao Liu; Syed A Ahmad; Oliver Stoeltzing; Niels Reinmuth; Diane Bielenberg; Corazon D Bucana; Michael Klagsbrun; Lee M Ellis
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

8.  Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.

Authors:  G R Johnson; T Saeki; A W Gordon; M Shoyab; D S Salomon; K Stromberg
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

9.  Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.

Authors:  Zhongsheng Peng; Jean-Pierre Raufman; Guofeng Xie
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

Authors:  Marta Rokita; Rafał Stec; Lubomir Bodnar; Radosław Charkiewicz; Jan Korniluk; Marta Smoter; Marzena Cichowicz; Lech Chyczewski; Jacek Nikliński; Wojciech Kozłowski; Cezary Szczylik
Journal:  Onco Targets Ther       Date:  2013-07-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.